NeuroMetrix, Inc. (NURO) - Product Pipeline Analysis

GlobalData, March 2011, Pages: 18

NeuroMetrix, Inc. (NURO) - Product Pipeline Analysis

Summary

This report is a source for data, analysis and actionable intelligence on the NeuroMetrix, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

2
List of Tables 3
List of Figures 3
Key Facts 4
NeuroMetrix, Inc. - Major Products and Services 5
NeuroMetrix, Inc. Pipeline Products by Equipment Type 6
NeuroMetrix, Inc. Pipeline Products by Development Stage 7
NeuroMetrix, Inc. Pipeline Products by Therapy Area 8
Intra-operative Peripheral Nerve Assessment and Monitoring Device 9
Product Status 9
Product Description 9
Nerve Stimulation Device 9
Product Status 9
Product Description 9
New Version-Ncstat-DPN 9
Product Status 9
Product Description 10
NeuroMetrix, Inc. - Key Competitors 11
NeuroMetrix, Inc. - Key Employees 12
NeuroMetrix, Inc. - Locations And Subsidiaries 13
Head Office 13
Recent Developments 14
Mar 03, 2011: NeuroMetrix Renews Credit Facility Agreement With Comerica Bank 14
Feb 03, 2011: NeuroMetrix Reports Total Revenues Of $13.90 Million In 2010 14
Jan 04, 2011: NeuroMetrix To Shift Business Focus To Diabetes 14
Dec 17, 2010: NeuroMetrix Names Nancy Katz To Board Of Directors 14
Nov 09, 2010: NeuroMetrix Reports Total Revenues Of $3.41 Million For Q3 2010 15
Sep 24, 2010: NeuroMetrix Receives NASDAQ Deficiency Notice 15
Aug 10, 2010: NeuroMetrix Reports Net Loss Of $4.5 Million For Q2 2010 15
Aug 10, 2010: NeuroMetrix Reports Net Income Of $194 Million In Q2 2010 16
May 11, 2010: NeuroMetrix Reports Total Revenues Of $3.7 million In Q1 2010 17
Apr 20, 2010: NeuroMetrix Names Krishnamurthy Balachandran As Senior Vice President & General Manager, International 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

BeneChill, Inc.
Avigen, Inc.
Alaven Pharmaceutical LLC
Aesculap, Inc.
Bio-logic Systems Corp

Customers who bought this item also bought

• eLEARNING - Global Strategic Business Report
• Charter Schools - Global Outlook
• Aerospace and Defense Industry - Global Strategic Business Report
• Sports and Fitness Nutrition - Global Strategic Business Report
• Education Services - Global Strategic Business Report
• Commercial And Military Flight Simulation - Global Strategic Business Report
• Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans
• The Worldwide Industry & Market Opportunities and forecasts to 2014 for Microwaves Global Military & Space-Related Systems
• Private Tutoring - Global Strategic Business Report
• Aerospace and Defense Industry - Global Outlook